<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01463917</url>
  </required_header>
  <id_info>
    <org_study_id>hypertonic off pump CABS</org_study_id>
    <nct_id>NCT01463917</nct_id>
  </id_info>
  <brief_title>Hypertonic Solution in Off Pump Coronary Artery Bypass Graft Surgery</brief_title>
  <official_title>Use of Hypertonic Versus Isotonic Solutions in Off Pump Coronary Artery Bypass Graft Surgery Targeting the Left Marginal Branch</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Pitangueiras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Pitangueiras</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a comparison between Hypertonic versus isotonic solution in a double blind randomized
      trial for off pump Coronary Artery Bypass Graft (CABG) surgery targeting the left marginal
      branch.

      Hypertonic solution should provide better tolerance for heart mobilization with less volume
      expansion and less drugs.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Use of vasoactive drugs in left marginal branch off pump CABG surgery</measure>
    <time_frame>time related to left branch coronary anastomosis for drug need.</time_frame>
    <description>Comparison between hypertonic and isotonic solutions for need of vasoactive drugs with heart mobilization during left marginal branch off pump CABG surgery. Data will be collected respectively at 1, 5 and 10 minutes after beggining the left branch coronary anastomosis. Data will be type of drug need and dosage until the end os the anastomosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluid balance</measure>
    <time_frame>Operative period and first operative day</time_frame>
    <description>Comparison of fluid balance in the operative period between hypertonic and isotonic solutions. Data will be collected at the end of surgery and by next mornning.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Hypertonic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of Hypertonic solution during left marginal branch CABG surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Use of Isotonic solution during left marginal branch CABG surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hypertonic solution</intervention_name>
    <description>Use of Hypertonic solution 4 ml/Kg during left marginal branch CABG surgery.</description>
    <arm_group_label>Hypertonic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic</intervention_name>
    <description>Use of Isotonic solution 4 ml/Kg during left marginal branch CABG surgery.</description>
    <arm_group_label>Isotonic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Off pump CABG targeting the left marginal branch

        Exclusion Criteria:

          -  On pump surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ROBERTO R Silva, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Pitangueiras</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberto R Silva, MD PHD</last_name>
    <phone>55-11-45215757</phone>
    <email>rochaesilva@incor.usp.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Pitangueiras</name>
      <address>
        <city>Jundiai</city>
        <state>Sao Paulo</state>
        <zip>1295</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo De Mola, MD</last_name>
      <phone>55-11-45276226</phone>
      <email>ricardo_485@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Ricardo De Mola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Velasco IT, Pontieri V, Rocha e Silva M Jr, Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol. 1980 Nov;239(5):H664-73.</citation>
    <PMID>6776826</PMID>
  </reference>
  <reference>
    <citation>Rocha e Silva M, Braga GA, Prist R, Velasco IT, Grança ES. Isochloremic hypertonic solutions for severe hemorrhage. J Trauma. 1993 Aug;35(2):200-5.</citation>
    <PMID>7689115</PMID>
  </reference>
  <reference>
    <citation>Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery. 1997 Sep;122(3):609-16.</citation>
    <PMID>9308620</PMID>
  </reference>
  <reference>
    <citation>Mazzoni MC, Borgström P, Intaglietta M, Arfors KE. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock. 1990 Aug;31(4):407-18.</citation>
    <PMID>1697790</PMID>
  </reference>
  <reference>
    <citation>Ramires JA, Serrano Júnior CV, César LA, Velasco IT, Rocha e Silva Júnior M, Pileggi F. Acute hemodynamic effects of hypertonic (7.5%) saline infusion in patients with cardiogenic shock due to right ventricular infarction. Circ Shock. 1992 Jul;37(3):220-5.</citation>
    <PMID>1423912</PMID>
  </reference>
  <reference>
    <citation>Auler JO Jr, Pereira MH, Gomide-Amaral RV, Stolf NG, Jatene AD, Rocha e Silva M. Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms. Surgery. 1987 May;101(5):594-601.</citation>
    <PMID>3576451</PMID>
  </reference>
  <reference>
    <citation>DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, Forest RJ, Pieroni JW, Warren CS, Bogosian ME, Krumholz CF, Clark C, Clough RA, Weldner PW, Lahey SJ, Leavitt BJ, Marrin CA, Charlesworth DC, Marshall P, O'Connor GT. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001 Mar;71(3):769-76.</citation>
    <PMID>11269449</PMID>
  </reference>
  <reference>
    <citation>Boldt J, Zickmann B, Ballesteros M, Herold C, Dapper F, Hempelmann G. Cardiorespiratory responses to hypertonic saline solution in cardiac operations. Ann Thorac Surg. 1991 Apr;51(4):610-5.</citation>
    <PMID>2012420</PMID>
  </reference>
  <reference>
    <citation>Boldt J, Zickmann B, Herold C, Ballesteros M, Dapper F, Hempelmann G. Influence of hypertonic volume replacement on the microcirculation in cardiac surgery. Br J Anaesth. 1991 Nov;67(5):595-602.</citation>
    <PMID>1721516</PMID>
  </reference>
  <reference>
    <citation>Oliveira SA, Bueno RM, Souza JM, Senra DF, Rocha-e-Silva M. Effects of hypertonic saline dextran on the postoperative evolution of Jehovah's Witness patients submitted to cardiac surgery with cardiopulmonary bypass. Shock. 1995 Jun;3(6):391-4.</citation>
    <PMID>7544684</PMID>
  </reference>
  <reference>
    <citation>Sirieix D, Hongnat JM, Delayance S, D'Attellis N, Vicaut E, Bérrébi A, Paris M, Fabiani JN, Carpentier A, Baron JF. Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med. 1999 Oct;27(10):2159-65.</citation>
    <PMID>10548199</PMID>
  </reference>
  <reference>
    <citation>Tølløfsrud S, Noddeland H. Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiol Scand. 1998 Feb;42(2):154-61.</citation>
    <PMID>9509195</PMID>
  </reference>
  <reference>
    <citation>Rocha-E-Silva R, Canêo LF, Lourenço Filho DD, Jatene MB, Barbero-Marcial M, Oliveira SA, Rocha-E-Silva M. First use of hypertonic saline dextran in children: a study in safety and effectiveness for atrial septal defect surgery. Shock. 2003 Nov;20(5):427-30.</citation>
    <PMID>14560106</PMID>
  </reference>
  <reference>
    <citation>Kvalheim VL, Farstad M, Steien E, Mongstad A, Borge BA, Kvitting PM, Husby P. Infusion of hypertonic saline/starch during cardiopulmonary bypass reduces fluid overload and may impact cardiac function. Acta Anaesthesiol Scand. 2010 Apr;54(4):485-93. doi: 10.1111/j.1399-6576.2009.02156.x. Epub 2009 Oct 29.</citation>
    <PMID>19878097</PMID>
  </reference>
  <reference>
    <citation>Mustafa I, Leverve XM. Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients. Shock. 2002 Oct;18(4):306-10.</citation>
    <PMID>12392272</PMID>
  </reference>
  <reference>
    <citation>Chang WI, Kim KB, Kim JH, Ham BM, Kim YL. Hemodynamic changes during posterior vessel off-pump coronary artery bypass: comparison between deep pericardial sutures and vacuum-assisted apical suction device. Ann Thorac Surg. 2004 Dec;78(6):2057-62.</citation>
    <PMID>15561035</PMID>
  </reference>
  <reference>
    <citation>Ozay B, Sargin M, Abay G, Ketenci B, Kut S, Enc Y, Orhan G, Teskin O, Demirtas M. The severity of positional mitral regurgitation during off-pump coronary artery bypass grafting. Heart Surg Forum. 2008;11(3):E145-51. doi: 10.1532/HSF98.20071191.</citation>
    <PMID>18583284</PMID>
  </reference>
  <reference>
    <citation>Mishra M, Malhotra R, Mishra A, Meharwal ZS, Trehan N. Hemodynamic changes during displacement of the beating heart using epicardial stabilization for off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2002 Dec;16(6):685-90.</citation>
    <PMID>12486647</PMID>
  </reference>
  <reference>
    <citation>Rocha-e-Silva M, Negraes GA, Soares AM, Pontieri V, Loppnow L. Hypertonic resuscitation from severe hemorrhagic shock: patterns of regional circulation. Circ Shock. 1986;19(2):165-75.</citation>
    <PMID>3719918</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2011</study_first_submitted>
  <study_first_submitted_qc>October 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2011</study_first_posted>
  <last_update_submitted>October 31, 2011</last_update_submitted>
  <last_update_submitted_qc>October 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Pitangueiras</investigator_affiliation>
    <investigator_full_name>Roberto Rocha e Silva</investigator_full_name>
    <investigator_title>Chief, Adult Heart Surgery, MD PHD in Cardiovascular Surgery</investigator_title>
  </responsible_party>
  <keyword>Coronary Artery Bypass</keyword>
  <keyword>Off-Pump</keyword>
  <keyword>Saline Solution</keyword>
  <keyword>Hypertonic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

